Publications by authors named "I Gardi"

There is a growing interest in arterial and heart valve calcifications, as these contribute to cardiovascular outcome, and are leading predictors of cardiovascular and kidney diseases. Cardiovascular calcifications are often considered as one disease, but, in effect, they represent multifaced disorders, occurring in different milieus and biological phenotypes, following different pathways. Herein, we explore each different molecular process, its relative link with the specific clinical condition, and the current therapeutic approaches to counteract calcifications.

View Article and Find Full Text PDF

Background: Coronavirus disease 2019 (COVID-19) has spread worldwide determining dramatic impacts on healthcare systems. Early identification of high-risk parameters is required in order to provide the best therapeutic approach. Coronary, thoracic aorta and aortic valve calcium can be measured from a non-gated chest computer tomography (CT) and are validated predictors of cardiovascular events and all-cause mortality.

View Article and Find Full Text PDF

Background: Valve-in-valve transcatheter aortic valve replacement (ViV-TAVR) is an emerging alternative to re-do surgery. However, the challenge of coronary access (CA) following ViV-TAVR is a potential limitation as TAVR expands to younger lower-risk populations.

Objectives: Using post-implantation computed tomography (CT) scans to evaluate the geometrical relationship between coronary ostia and valve frame in patients undergoing ViV-TAVR with the ACURATE neo valve.

View Article and Find Full Text PDF

Contrast-induced acute kidney injury (CI-AKI) represents a common but serious complication of percutaneous coronary interventions (PCI)-and in general of all those examinations requiring iodinated contrast injection-which affects not only renal function but also long-term prognosis. While several prophylactic approaches were designed in order to prevent CI-AKI, most failed to demonstrate clear benefits in randomized trials, and their implementation is therefore discouraged in clinical practice. The most notorious examples include pre-procedural bicarbonate or N-acetylcysteine, and preprocedural withdrawal of ACE inhibitors/Angiotensin receptor blockers.

View Article and Find Full Text PDF

A novel, stimuli-responsive composite, based on poly(4-vinylpyridine) (PVP) brushes, end-grafted to montmorillonite clay (GPC), was designed as a regenerable sorbent for efficient removal of pollutants from water. We characterized the novel composite sorbent and its response to pH, employing Fourier transform infrared, X-ray photoelectron spectroscopy, X-ray diffraction, thermogravimetry analysis and zeta potential measurements. In comparison with conventional, electrostatically adsorbed PVP composites (APC), the GPC presented superior characteristics: higher polymer loading without polymer release, higher zeta potential and lower pH/charge dependency.

View Article and Find Full Text PDF